OLIVIA AKPAIBOR: Open Payments
NPI 1396110193 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 2 payments from 2 companies in 2025. Trend: 2023 $201 · 2024 $477 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $135 |
| Janssen Pharmaceuticals, Inc | 1 | $115 |
Products named: INGREZZA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
